カテゴリー： Market Monitor Global, 世界, 医療/バイオ

慢性痛風治療薬のグローバル市場展望 2023年-2029年：錠剤、カプセル、その他

◆英語タイトル：Chronic Gout Treatment Drug Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23DC14279）

◆商品コード：MMG23DC14279
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年12月（※2025年版があります。お問い合わせください。）
◆ページ数：120
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医薬品

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥468,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥608,400	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥702,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

慢性痛風は、尿酸値の上昇によって引き起こされる代謝性疾患であり、関節や周囲の組織に尿酸結晶が沈着することによって激しい痛みや炎症を引き起こします。この病状は、時折痛風発作として急性の症状を呈し、放置すると関節の損傷や腎臓の障害を引き起こす可能性があります。そのため、慢性痛風の治療には、尿酸値をコントロールし、痛風発作を予防することが重要です。ここでは、慢性痛風治療薬の概念、特徴、主な種類、用途や関連技術について詳述します。

慢性痛風治療薬の定義は、血中尿酸濃度を低下させ、痛風発作を予防・治療するために使用される薬剤と説明できます。治療薬は、痛風の長期管理において中心的な役割を果たしており、尿酸値の持続的なコントロールを実現することが治療の目標です。

慢性痛風治療薬の特徴として、血中尿酸値を低下させる効果が挙げられます。通常、尿酸値が7.0 mg/dLを超えると痛風のリスクが高まり、8.0 mg/dLを超えると発作が起こる可能性が高まります。そのため、慢性痛風の治療では、尿酸値を適切に管理することが求められます。また、これらの薬剤は、尿酸を生成する酵素の働きを抑えるものや、尿酸の排泄を促進するもの、さらには尿酸の再吸収を抑えるものなど、作用機序が多岐にわたります。

慢性痛風治療薬の主な種類には、以下のようなものがあります。

一つ目は、尿酸生成抑制薬です。代表的な薬剤にはアロプリノールやフェブキソスタットがあります。アロプリノールは、キサンチンオキシダーゼという酵素を阻害することで、尿酸の生成を抑えます。また、フェブキソスタットも同様の作用を持ち、アロプリノールに比べて腎機能に優しいとされることがあります。これらの薬剤は、尿酸値の持続的な低下を目指す治療において、第一選択薬とされています。

二つ目は、尿酸排泄促進薬です。プロベネシドやベンズブロマロンといった薬剤が代表的です。これらは腎臓における尿酸の再吸収を抑え、尿中への排泄を促進です。尿酸値を低下させることに加え、尿酸結晶の形成を抑制する効果も期待できますが、腎機能に障害がある患者には使用が制限されることがあります。

三つ目は、特定の痛風発作に対する治療薬です。コルヒチンや非ステロイド性抗炎症薬（NSAIDs）がこれにあたります。コルヒチンは、炎症反応を抑える作用があり、発作初期に使用されることが一般的です。一方、NSAIDsは痛みや炎症を緩和するために使用され、発作の緩和を図ります。ただし、これらは慢性痛風の原因となる尿酸管理には直接寄与しないため、発作が起こった際の対症療法としての位置付けです。

慢性痛風治療薬の用途は、尿酸値の管理と痛風発作の予防・治療に集中しています。特に、高尿酸血症を持つ患者においては、慢性的に尿酸値を下げることが求められます。これにより、痛風発作の頻度を減らし、関節や腎臓などの合併症を予防する目的があります。具体的には、尿酸値を7.0 mg/dL未満に維持することが一般的な目標とされています。

また、慢性痛風治療薬は、個々の患者の状態に応じて適切に選択される必要があります。腎機能、他の疾患の有無、関連する合併症などを踏まえた上で、最適な薬剤を選定することが重要です。また、定期的な血液検査を通じて、薬剤の効果や副作用をモニタリングしながら治療を進めることも不可欠です。

最近では、新しい治療戦略も登場しています。例えば、尿酸値を下げるだけでなく、抗炎症作用を有する薬剤も研究されています。これにより、痛風発作や痛風による合併症のリスクをさらに低減させることが期待されています。バイオ製剤や新しい目的の治療法も開発が進められており、今後の進展が待たれます。

慢性痛風治療薬と関連技術の開発は、個別化医療の観点からも重要です。患者の遺伝的背景や環境要因に基づいた治療法の選択が進むことで、より効果的な治療が実現する可能性があります。例えば、遺伝子解析を通じて、特定の治療薬に対してどのように反応するかを予測する技術が進化することで、患者ごとの最適な治療方針が立てやすくなります。

慢性痛風治療薬の使用にあたっては、副作用や相互作用にも注意が必要です。例えば、アロプリノールは過敏症や皮膚反応を引き起こすことがあるため、服用中は注意深く経過観察を行うべきです。また、尿酸排泄促進薬は腎臓に負担をかける可能性があるため、腎機能の状態を定期的にチェックする必要があります。患者が安心して治療を受けるためには、医療者との密なコミュニケーションが不可欠です。

包括的な慢性痛風の管理には、薬物治療だけでなく、生活習慣の改善も含まれます。適切な食事指導や運動療法、体重管理などが推奨され、患者の生活の質の向上を目指します。食事ではプリン体を含む食品の摂取を控えることが重要であり、特に赤身肉や内臓肉の摂取制限が役立つ場合があります。

慢性痛風治療薬は、痛風の長期管理において必須の要素ですが、薬物療法だけに頼るのではなく、総合的なアプローチが求められます。進行する研究や技術の進展により、より効果的で安全な治療が確立されることが期待されており、今後の動向にも注目が集まっています。慢性痛風管理の新たな可能性を追求しつつ、患者一人ひとりに寄り添った治療を実践することが求められています。これにより、慢性痛風患者の生活の質を向上させることが可能となり、痛風による障害から解放される日も近いと考えられます。

当調査レポートは次の情報を含め、世界の慢性痛風治療薬市場規模と予測を収録しています。・世界の慢性痛風治療薬市場：売上、2018年-2023年、2024年-2029年
・世界の慢性痛風治療薬市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の慢性痛風治療薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「錠剤」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

慢性痛風治療薬のグローバル主要企業は、GE Healthcare、 AstraZeneca、 Pfizer、 Merck、 Novartis、 Takeda Pharmaceuticals、 Sanofi、 Boston Biomedical、 Tianjin Kingyork Group、 Atom Bioscience and Pharmaceutical、 Wuhan Humanwell Pharmaceutical Group、 Fosun Pharma、 Chongqing Taiji Industryなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、慢性痛風治療薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の慢性痛風治療薬市場：タイプ別、2018年-2023年、2024年-2029年
世界の慢性痛風治療薬市場：タイプ別市場シェア、2022年
・錠剤、カプセル、その他

世界の慢性痛風治療薬市場：用途別、2018年-2023年、2024年-2029年
世界の慢性痛風治療薬市場：用途別市場シェア、2022年
・総合病院、専門病院、その他

世界の慢性痛風治療薬市場：地域・国別、2018年-2023年、2024年-2029年
世界の慢性痛風治療薬市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における慢性痛風治療薬のグローバル売上、2018年-2023年
・主要企業における慢性痛風治療薬のグローバル売上シェア、2022年
・主要企業における慢性痛風治療薬のグローバル販売量、2018年-2023年
・主要企業における慢性痛風治療薬のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
GE Healthcare、 AstraZeneca、 Pfizer、 Merck、 Novartis、 Takeda Pharmaceuticals、 Sanofi、 Boston Biomedical、 Tianjin Kingyork Group、 Atom Bioscience and Pharmaceutical、 Wuhan Humanwell Pharmaceutical Group、 Fosun Pharma、 Chongqing Taiji Industry

*************************************************************

・調査・分析レポートの概要
慢性痛風治療薬市場の定義
市場セグメント
世界の慢性痛風治療薬市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の慢性痛風治療薬市場規模
世界の慢性痛風治療薬市場規模：2022年 VS 2029年
世界の慢性痛風治療薬市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの慢性痛風治療薬の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の慢性痛風治療薬製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：錠剤、カプセル、その他
慢性痛風治療薬のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：総合病院、専門病院、その他
慢性痛風治療薬の用途別グローバル売上・予測

・地域別市場分析
地域別慢性痛風治療薬市場規模 2022年と2029年
地域別慢性痛風治療薬売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
GE Healthcare、 AstraZeneca、 Pfizer、 Merck、 Novartis、 Takeda Pharmaceuticals、 Sanofi、 Boston Biomedical、 Tianjin Kingyork Group、 Atom Bioscience and Pharmaceutical、 Wuhan Humanwell Pharmaceutical Group、 Fosun Pharma、 Chongqing Taiji Industry
...

This research report provides a comprehensive analysis of the Chronic Gout Treatment Drug market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Chronic Gout Treatment Drug market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Chronic Gout Treatment Drug, challenges faced by the industry, and potential opportunities for market players.
The global Chronic Gout Treatment Drug market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Chronic Gout Treatment Drug market presents opportunities for various stakeholders, including General Hospital, Specialty Hospital. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Chronic Gout Treatment Drug market. Additionally, the growing consumer demand present avenues for market expansion.
The global Chronic Gout Treatment Drug market was valued at US$ 1134.6 million in 2022 and is projected to reach US$ 1563.9 million by 2029, at a CAGR of 4.7% during the forecast period.
Chronic gout is a metabolic disease often associated with high uric acid levels and the deposition of uric acid crystals. The main goals of chronic gout treatment medications are to reduce the symptoms of gout attacks, lower uric acid levels, and prevent the formation of uric acid crystals. As medicine advances, more and more research is focusing on personalized treatment, selecting the best treatment method based on the patient’s genetic and physiological characteristics. Developments in pharmaceutical technology have made drug delivery more convenient and consistent, thereby improving treatment compliance.
Key Features:
The research report on the Chronic Gout Treatment Drug market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Chronic Gout Treatment Drug market.
Market Overview: The report provides a comprehensive overview of the Chronic Gout Treatment Drug market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Pill, Capsule), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Chronic Gout Treatment Drug market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Chronic Gout Treatment Drug market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Chronic Gout Treatment Drug market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Chronic Gout Treatment Drug market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Chronic Gout Treatment Drug market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Chronic Gout Treatment Drug market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Chronic Gout Treatment Drug, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Chronic Gout Treatment Drug market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Chronic Gout Treatment Drug market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Pill
Capsule
Others
Market segment by Application
General Hospital
Specialty Hospital
Others
Global Chronic Gout Treatment Drug Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
GE Healthcare
AstraZeneca
Pfizer
Merck
Novartis
Takeda Pharmaceuticals
Sanofi
Boston Biomedical
Tianjin Kingyork Group
Atom Bioscience and Pharmaceutical
Wuhan Humanwell Pharmaceutical Group
Fosun Pharma
Chongqing Taiji Industry
Outline of Major Chapters:
Chapter 1: Introduces the definition of Chronic Gout Treatment Drug, market overview.
Chapter 2: Global Chronic Gout Treatment Drug market size in revenue and volume.
Chapter 3: Detailed analysis of Chronic Gout Treatment Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Chronic Gout Treatment Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Chronic Gout Treatment Drug capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Chronic Gout Treatment Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Chronic Gout Treatment Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Chronic Gout Treatment Drug Overall Market Size
2.1 Global Chronic Gout Treatment Drug Market Size: 2022 VS 2029
2.2 Global Chronic Gout Treatment Drug Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Chronic Gout Treatment Drug Sales: 2018-2029
3 Company Landscape
3.1 Top Chronic Gout Treatment Drug Players in Global Market
3.2 Top Global Chronic Gout Treatment Drug Companies Ranked by Revenue
3.3 Global Chronic Gout Treatment Drug Revenue by Companies
3.4 Global Chronic Gout Treatment Drug Sales by Companies
3.5 Global Chronic Gout Treatment Drug Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Chronic Gout Treatment Drug Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Chronic Gout Treatment Drug Product Type
3.8 Tier 1, Tier 2 and Tier 3 Chronic Gout Treatment Drug Players in Global Market
3.8.1 List of Global Tier 1 Chronic Gout Treatment Drug Companies
3.8.2 List of Global Tier 2 and Tier 3 Chronic Gout Treatment Drug Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Chronic Gout Treatment Drug Market Size Markets, 2022 & 2029
4.1.2 Pill
4.1.3 Capsule
4.1.4 Others
4.2 By Type – Global Chronic Gout Treatment Drug Revenue & Forecasts
4.2.1 By Type – Global Chronic Gout Treatment Drug Revenue, 2018-2023
4.2.2 By Type – Global Chronic Gout Treatment Drug Revenue, 2024-2029
4.2.3 By Type – Global Chronic Gout Treatment Drug Revenue Market Share, 2018-2029
4.3 By Type – Global Chronic Gout Treatment Drug Sales & Forecasts
4.3.1 By Type – Global Chronic Gout Treatment Drug Sales, 2018-2023
4.3.2 By Type – Global Chronic Gout Treatment Drug Sales, 2024-2029
4.3.3 By Type – Global Chronic Gout Treatment Drug Sales Market Share, 2018-2029
4.4 By Type – Global Chronic Gout Treatment Drug Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Chronic Gout Treatment Drug Market Size, 2022 & 2029
5.1.2 General Hospital
5.1.3 Specialty Hospital
5.1.4 Others
5.2 By Application – Global Chronic Gout Treatment Drug Revenue & Forecasts
5.2.1 By Application – Global Chronic Gout Treatment Drug Revenue, 2018-2023
5.2.2 By Application – Global Chronic Gout Treatment Drug Revenue, 2024-2029
5.2.3 By Application – Global Chronic Gout Treatment Drug Revenue Market Share, 2018-2029
5.3 By Application – Global Chronic Gout Treatment Drug Sales & Forecasts
5.3.1 By Application – Global Chronic Gout Treatment Drug Sales, 2018-2023
5.3.2 By Application – Global Chronic Gout Treatment Drug Sales, 2024-2029
5.3.3 By Application – Global Chronic Gout Treatment Drug Sales Market Share, 2018-2029
5.4 By Application – Global Chronic Gout Treatment Drug Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Chronic Gout Treatment Drug Market Size, 2022 & 2029
6.2 By Region – Global Chronic Gout Treatment Drug Revenue & Forecasts
6.2.1 By Region – Global Chronic Gout Treatment Drug Revenue, 2018-2023
6.2.2 By Region – Global Chronic Gout Treatment Drug Revenue, 2024-2029
6.2.3 By Region – Global Chronic Gout Treatment Drug Revenue Market Share, 2018-2029
6.3 By Region – Global Chronic Gout Treatment Drug Sales & Forecasts
6.3.1 By Region – Global Chronic Gout Treatment Drug Sales, 2018-2023
6.3.2 By Region – Global Chronic Gout Treatment Drug Sales, 2024-2029
6.3.3 By Region – Global Chronic Gout Treatment Drug Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Chronic Gout Treatment Drug Revenue, 2018-2029
6.4.2 By Country – North America Chronic Gout Treatment Drug Sales, 2018-2029
6.4.3 US Chronic Gout Treatment Drug Market Size, 2018-2029
6.4.4 Canada Chronic Gout Treatment Drug Market Size, 2018-2029
6.4.5 Mexico Chronic Gout Treatment Drug Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Chronic Gout Treatment Drug Revenue, 2018-2029
6.5.2 By Country – Europe Chronic Gout Treatment Drug Sales, 2018-2029
6.5.3 Germany Chronic Gout Treatment Drug Market Size, 2018-2029
6.5.4 France Chronic Gout Treatment Drug Market Size, 2018-2029
6.5.5 U.K. Chronic Gout Treatment Drug Market Size, 2018-2029
6.5.6 Italy Chronic Gout Treatment Drug Market Size, 2018-2029
6.5.7 Russia Chronic Gout Treatment Drug Market Size, 2018-2029
6.5.8 Nordic Countries Chronic Gout Treatment Drug Market Size, 2018-2029
6.5.9 Benelux Chronic Gout Treatment Drug Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Chronic Gout Treatment Drug Revenue, 2018-2029
6.6.2 By Region – Asia Chronic Gout Treatment Drug Sales, 2018-2029
6.6.3 China Chronic Gout Treatment Drug Market Size, 2018-2029
6.6.4 Japan Chronic Gout Treatment Drug Market Size, 2018-2029
6.6.5 South Korea Chronic Gout Treatment Drug Market Size, 2018-2029
6.6.6 Southeast Asia Chronic Gout Treatment Drug Market Size, 2018-2029
6.6.7 India Chronic Gout Treatment Drug Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Chronic Gout Treatment Drug Revenue, 2018-2029
6.7.2 By Country – South America Chronic Gout Treatment Drug Sales, 2018-2029
6.7.3 Brazil Chronic Gout Treatment Drug Market Size, 2018-2029
6.7.4 Argentina Chronic Gout Treatment Drug Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Chronic Gout Treatment Drug Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Chronic Gout Treatment Drug Sales, 2018-2029
6.8.3 Turkey Chronic Gout Treatment Drug Market Size, 2018-2029
6.8.4 Israel Chronic Gout Treatment Drug Market Size, 2018-2029
6.8.5 Saudi Arabia Chronic Gout Treatment Drug Market Size, 2018-2029
6.8.6 UAE Chronic Gout Treatment Drug Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 GE Healthcare
7.1.1 GE Healthcare Company Summary
7.1.2 GE Healthcare Business Overview
7.1.3 GE Healthcare Chronic Gout Treatment Drug Major Product Offerings
7.1.4 GE Healthcare Chronic Gout Treatment Drug Sales and Revenue in Global (2018-2023)
7.1.5 GE Healthcare Key News & Latest Developments
7.2 AstraZeneca
7.2.1 AstraZeneca Company Summary
7.2.2 AstraZeneca Business Overview
7.2.3 AstraZeneca Chronic Gout Treatment Drug Major Product Offerings
7.2.4 AstraZeneca Chronic Gout Treatment Drug Sales and Revenue in Global (2018-2023)
7.2.5 AstraZeneca Key News & Latest Developments
7.3 Pfizer
7.3.1 Pfizer Company Summary
7.3.2 Pfizer Business Overview
7.3.3 Pfizer Chronic Gout Treatment Drug Major Product Offerings
7.3.4 Pfizer Chronic Gout Treatment Drug Sales and Revenue in Global (2018-2023)
7.3.5 Pfizer Key News & Latest Developments
7.4 Merck
7.4.1 Merck Company Summary
7.4.2 Merck Business Overview
7.4.3 Merck Chronic Gout Treatment Drug Major Product Offerings
7.4.4 Merck Chronic Gout Treatment Drug Sales and Revenue in Global (2018-2023)
7.4.5 Merck Key News & Latest Developments
7.5 Novartis
7.5.1 Novartis Company Summary
7.5.2 Novartis Business Overview
7.5.3 Novartis Chronic Gout Treatment Drug Major Product Offerings
7.5.4 Novartis Chronic Gout Treatment Drug Sales and Revenue in Global (2018-2023)
7.5.5 Novartis Key News & Latest Developments
7.6 Takeda Pharmaceuticals
7.6.1 Takeda Pharmaceuticals Company Summary
7.6.2 Takeda Pharmaceuticals Business Overview
7.6.3 Takeda Pharmaceuticals Chronic Gout Treatment Drug Major Product Offerings
7.6.4 Takeda Pharmaceuticals Chronic Gout Treatment Drug Sales and Revenue in Global (2018-2023)
7.6.5 Takeda Pharmaceuticals Key News & Latest Developments
7.7 Sanofi
7.7.1 Sanofi Company Summary
7.7.2 Sanofi Business Overview
7.7.3 Sanofi Chronic Gout Treatment Drug Major Product Offerings
7.7.4 Sanofi Chronic Gout Treatment Drug Sales and Revenue in Global (2018-2023)
7.7.5 Sanofi Key News & Latest Developments
7.8 Boston Biomedical
7.8.1 Boston Biomedical Company Summary
7.8.2 Boston Biomedical Business Overview
7.8.3 Boston Biomedical Chronic Gout Treatment Drug Major Product Offerings
7.8.4 Boston Biomedical Chronic Gout Treatment Drug Sales and Revenue in Global (2018-2023)
7.8.5 Boston Biomedical Key News & Latest Developments
7.9 Tianjin Kingyork Group
7.9.1 Tianjin Kingyork Group Company Summary
7.9.2 Tianjin Kingyork Group Business Overview
7.9.3 Tianjin Kingyork Group Chronic Gout Treatment Drug Major Product Offerings
7.9.4 Tianjin Kingyork Group Chronic Gout Treatment Drug Sales and Revenue in Global (2018-2023)
7.9.5 Tianjin Kingyork Group Key News & Latest Developments
7.10 Atom Bioscience and Pharmaceutical
7.10.1 Atom Bioscience and Pharmaceutical Company Summary
7.10.2 Atom Bioscience and Pharmaceutical Business Overview
7.10.3 Atom Bioscience and Pharmaceutical Chronic Gout Treatment Drug Major Product Offerings
7.10.4 Atom Bioscience and Pharmaceutical Chronic Gout Treatment Drug Sales and Revenue in Global (2018-2023)
7.10.5 Atom Bioscience and Pharmaceutical Key News & Latest Developments
7.11 Wuhan Humanwell Pharmaceutical Group
7.11.1 Wuhan Humanwell Pharmaceutical Group Company Summary
7.11.2 Wuhan Humanwell Pharmaceutical Group Business Overview
7.11.3 Wuhan Humanwell Pharmaceutical Group Chronic Gout Treatment Drug Major Product Offerings
7.11.4 Wuhan Humanwell Pharmaceutical Group Chronic Gout Treatment Drug Sales and Revenue in Global (2018-2023)
7.11.5 Wuhan Humanwell Pharmaceutical Group Key News & Latest Developments
7.12 Fosun Pharma
7.12.1 Fosun Pharma Company Summary
7.12.2 Fosun Pharma Business Overview
7.12.3 Fosun Pharma Chronic Gout Treatment Drug Major Product Offerings
7.12.4 Fosun Pharma Chronic Gout Treatment Drug Sales and Revenue in Global (2018-2023)
7.12.5 Fosun Pharma Key News & Latest Developments
7.13 Chongqing Taiji Industry
7.13.1 Chongqing Taiji Industry Company Summary
7.13.2 Chongqing Taiji Industry Business Overview
7.13.3 Chongqing Taiji Industry Chronic Gout Treatment Drug Major Product Offerings
7.13.4 Chongqing Taiji Industry Chronic Gout Treatment Drug Sales and Revenue in Global (2018-2023)
7.13.5 Chongqing Taiji Industry Key News & Latest Developments
8 Global Chronic Gout Treatment Drug Production Capacity, Analysis
8.1 Global Chronic Gout Treatment Drug Production Capacity, 2018-2029
8.2 Chronic Gout Treatment Drug Production Capacity of Key Manufacturers in Global Market
8.3 Global Chronic Gout Treatment Drug Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Chronic Gout Treatment Drug Supply Chain Analysis
10.1 Chronic Gout Treatment Drug Industry Value Chain
10.2 Chronic Gout Treatment Drug Upstream Market
10.3 Chronic Gout Treatment Drug Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Chronic Gout Treatment Drug Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Chronic Gout Treatment Drug in Global Market
Table 2. Top Chronic Gout Treatment Drug Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Chronic Gout Treatment Drug Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Chronic Gout Treatment Drug Revenue Share by Companies, 2018-2023
Table 5. Global Chronic Gout Treatment Drug Sales by Companies, (K Units), 2018-2023
Table 6. Global Chronic Gout Treatment Drug Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Chronic Gout Treatment Drug Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Chronic Gout Treatment Drug Product Type
Table 9. List of Global Tier 1 Chronic Gout Treatment Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Chronic Gout Treatment Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Chronic Gout Treatment Drug Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Chronic Gout Treatment Drug Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Chronic Gout Treatment Drug Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Chronic Gout Treatment Drug Sales (K Units), 2018-2023
Table 15. By Type - Global Chronic Gout Treatment Drug Sales (K Units), 2024-2029
Table 16. By Application – Global Chronic Gout Treatment Drug Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Chronic Gout Treatment Drug Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Chronic Gout Treatment Drug Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Chronic Gout Treatment Drug Sales (K Units), 2018-2023
Table 20. By Application - Global Chronic Gout Treatment Drug Sales (K Units), 2024-2029
Table 21. By Region – Global Chronic Gout Treatment Drug Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Chronic Gout Treatment Drug Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Chronic Gout Treatment Drug Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Chronic Gout Treatment Drug Sales (K Units), 2018-2023
Table 25. By Region - Global Chronic Gout Treatment Drug Sales (K Units), 2024-2029
Table 26. By Country - North America Chronic Gout Treatment Drug Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Chronic Gout Treatment Drug Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Chronic Gout Treatment Drug Sales, (K Units), 2018-2023
Table 29. By Country - North America Chronic Gout Treatment Drug Sales, (K Units), 2024-2029
Table 30. By Country - Europe Chronic Gout Treatment Drug Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Chronic Gout Treatment Drug Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Chronic Gout Treatment Drug Sales, (K Units), 2018-2023
Table 33. By Country - Europe Chronic Gout Treatment Drug Sales, (K Units), 2024-2029
Table 34. By Region - Asia Chronic Gout Treatment Drug Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Chronic Gout Treatment Drug Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Chronic Gout Treatment Drug Sales, (K Units), 2018-2023
Table 37. By Region - Asia Chronic Gout Treatment Drug Sales, (K Units), 2024-2029
Table 38. By Country - South America Chronic Gout Treatment Drug Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Chronic Gout Treatment Drug Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Chronic Gout Treatment Drug Sales, (K Units), 2018-2023
Table 41. By Country - South America Chronic Gout Treatment Drug Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Chronic Gout Treatment Drug Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Chronic Gout Treatment Drug Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Chronic Gout Treatment Drug Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Chronic Gout Treatment Drug Sales, (K Units), 2024-2029
Table 46. GE Healthcare Company Summary
Table 47. GE Healthcare Chronic Gout Treatment Drug Product Offerings
Table 48. GE Healthcare Chronic Gout Treatment Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. GE Healthcare Key News & Latest Developments
Table 50. AstraZeneca Company Summary
Table 51. AstraZeneca Chronic Gout Treatment Drug Product Offerings
Table 52. AstraZeneca Chronic Gout Treatment Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. AstraZeneca Key News & Latest Developments
Table 54. Pfizer Company Summary
Table 55. Pfizer Chronic Gout Treatment Drug Product Offerings
Table 56. Pfizer Chronic Gout Treatment Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Pfizer Key News & Latest Developments
Table 58. Merck Company Summary
Table 59. Merck Chronic Gout Treatment Drug Product Offerings
Table 60. Merck Chronic Gout Treatment Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Merck Key News & Latest Developments
Table 62. Novartis Company Summary
Table 63. Novartis Chronic Gout Treatment Drug Product Offerings
Table 64. Novartis Chronic Gout Treatment Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. Novartis Key News & Latest Developments
Table 66. Takeda Pharmaceuticals Company Summary
Table 67. Takeda Pharmaceuticals Chronic Gout Treatment Drug Product Offerings
Table 68. Takeda Pharmaceuticals Chronic Gout Treatment Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. Takeda Pharmaceuticals Key News & Latest Developments
Table 70. Sanofi Company Summary
Table 71. Sanofi Chronic Gout Treatment Drug Product Offerings
Table 72. Sanofi Chronic Gout Treatment Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Sanofi Key News & Latest Developments
Table 74. Boston Biomedical Company Summary
Table 75. Boston Biomedical Chronic Gout Treatment Drug Product Offerings
Table 76. Boston Biomedical Chronic Gout Treatment Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. Boston Biomedical Key News & Latest Developments
Table 78. Tianjin Kingyork Group Company Summary
Table 79. Tianjin Kingyork Group Chronic Gout Treatment Drug Product Offerings
Table 80. Tianjin Kingyork Group Chronic Gout Treatment Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. Tianjin Kingyork Group Key News & Latest Developments
Table 82. Atom Bioscience and Pharmaceutical Company Summary
Table 83. Atom Bioscience and Pharmaceutical Chronic Gout Treatment Drug Product Offerings
Table 84. Atom Bioscience and Pharmaceutical Chronic Gout Treatment Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 85. Atom Bioscience and Pharmaceutical Key News & Latest Developments
Table 86. Wuhan Humanwell Pharmaceutical Group Company Summary
Table 87. Wuhan Humanwell Pharmaceutical Group Chronic Gout Treatment Drug Product Offerings
Table 88. Wuhan Humanwell Pharmaceutical Group Chronic Gout Treatment Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 89. Wuhan Humanwell Pharmaceutical Group Key News & Latest Developments
Table 90. Fosun Pharma Company Summary
Table 91. Fosun Pharma Chronic Gout Treatment Drug Product Offerings
Table 92. Fosun Pharma Chronic Gout Treatment Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 93. Fosun Pharma Key News & Latest Developments
Table 94. Chongqing Taiji Industry Company Summary
Table 95. Chongqing Taiji Industry Chronic Gout Treatment Drug Product Offerings
Table 96. Chongqing Taiji Industry Chronic Gout Treatment Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 97. Chongqing Taiji Industry Key News & Latest Developments
Table 98. Chronic Gout Treatment Drug Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 99. Global Chronic Gout Treatment Drug Capacity Market Share of Key Manufacturers, 2021-2023
Table 100. Global Chronic Gout Treatment Drug Production by Region, 2018-2023 (K Units)
Table 101. Global Chronic Gout Treatment Drug Production by Region, 2024-2029 (K Units)
Table 102. Chronic Gout Treatment Drug Market Opportunities & Trends in Global Market
Table 103. Chronic Gout Treatment Drug Market Drivers in Global Market
Table 104. Chronic Gout Treatment Drug Market Restraints in Global Market
Table 105. Chronic Gout Treatment Drug Raw Materials
Table 106. Chronic Gout Treatment Drug Raw Materials Suppliers in Global Market
Table 107. Typical Chronic Gout Treatment Drug Downstream
Table 108. Chronic Gout Treatment Drug Downstream Clients in Global Market
Table 109. Chronic Gout Treatment Drug Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Chronic Gout Treatment Drug Segment by Type in 2022
Figure 2. Chronic Gout Treatment Drug Segment by Application in 2022
Figure 3. Global Chronic Gout Treatment Drug Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Chronic Gout Treatment Drug Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Chronic Gout Treatment Drug Revenue, 2018-2029 (US$, Mn)
Figure 7. Chronic Gout Treatment Drug Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Chronic Gout Treatment Drug Revenue in 2022
Figure 9. By Type - Global Chronic Gout Treatment Drug Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Chronic Gout Treatment Drug Revenue Market Share, 2018-2029
Figure 11. By Type - Global Chronic Gout Treatment Drug Sales Market Share, 2018-2029
Figure 12. By Type - Global Chronic Gout Treatment Drug Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Chronic Gout Treatment Drug Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Chronic Gout Treatment Drug Revenue Market Share, 2018-2029
Figure 15. By Application - Global Chronic Gout Treatment Drug Sales Market Share, 2018-2029
Figure 16. By Application - Global Chronic Gout Treatment Drug Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Chronic Gout Treatment Drug Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Chronic Gout Treatment Drug Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Chronic Gout Treatment Drug Revenue Market Share, 2018-2029
Figure 20. By Region - Global Chronic Gout Treatment Drug Sales Market Share, 2018-2029
Figure 21. By Country - North America Chronic Gout Treatment Drug Revenue Market Share, 2018-2029
Figure 22. By Country - North America Chronic Gout Treatment Drug Sales Market Share, 2018-2029
Figure 23. US Chronic Gout Treatment Drug Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Chronic Gout Treatment Drug Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Chronic Gout Treatment Drug Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Chronic Gout Treatment Drug Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Chronic Gout Treatment Drug Sales Market Share, 2018-2029
Figure 28. Germany Chronic Gout Treatment Drug Revenue, (US$, Mn), 2018-2029
Figure 29. France Chronic Gout Treatment Drug Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Chronic Gout Treatment Drug Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Chronic Gout Treatment Drug Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Chronic Gout Treatment Drug Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Chronic Gout Treatment Drug Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Chronic Gout Treatment Drug Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Chronic Gout Treatment Drug Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Chronic Gout Treatment Drug Sales Market Share, 2018-2029
Figure 37. China Chronic Gout Treatment Drug Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Chronic Gout Treatment Drug Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Chronic Gout Treatment Drug Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Chronic Gout Treatment Drug Revenue, (US$, Mn), 2018-2029
Figure 41. India Chronic Gout Treatment Drug Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Chronic Gout Treatment Drug Revenue Market Share, 2018-2029
Figure 43. By Country - South America Chronic Gout Treatment Drug Sales Market Share, 2018-2029
Figure 44. Brazil Chronic Gout Treatment Drug Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Chronic Gout Treatment Drug Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Chronic Gout Treatment Drug Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Chronic Gout Treatment Drug Sales Market Share, 2018-2029
Figure 48. Turkey Chronic Gout Treatment Drug Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Chronic Gout Treatment Drug Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Chronic Gout Treatment Drug Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Chronic Gout Treatment Drug Revenue, (US$, Mn), 2018-2029
Figure 52. Global Chronic Gout Treatment Drug Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Chronic Gout Treatment Drug by Region, 2022 VS 2029
Figure 54. Chronic Gout Treatment Drug Industry Value Chain
Figure 55. Marketing Channels

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 慢性痛風治療薬のグローバル市場展望 2023年-2029年：錠剤、カプセル、その他(Chronic Gout Treatment Drug Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

慢性痛風治療薬のグローバル市場展望 2023年-2029年：錠剤、カプセル、その他

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp